ISPOR Europe 2025 was a great opportunity for Access Infinity to showcase key highlights from our consulting teams’ work. Below you’ll find an overview of the projects we presented.

Our posters demonstrated practical solutions to complex market access challenges, innovative digital methodologies, and strategic frameworks that support evidence, pricing, and access teams in making faster, more informed decisions. These contributions underline our role as a trusted partner in helping clients navigate evolving healthcare systems and optimise launch outcomes.

Explore the scenarios our consulting team presented below:

Poster 1: Global Payer Policies Potentially Impacting Pharma Pricing And Market Access Strategies? A Review Of Six Key Trends Shaping Pharma Future 

Poster 2: HTA Readiness For Tumor-Agnostic Therapies - Lessons From Analogues Across Major Markets 

Poster 3: Competing Beyond The First Mover - How Late To Market Analogues Navigate Pricing and Access In Major Global Markets?

Poster 4: Predicting the maximum fair price (MFP) from Medicare negotiations

Poster 5: Guideline-Driven Off-Label Oncology Use- The Role of Clinical Evidence and Reimbursement Dynamics in the EU4+UK, Switzerland and Canada

Poster 6: Artificial Intelligence in Pharmaceutical Payer Decision Making- Assessing Current Use, Strategic Intent, and Infrastructure Readiness

Poster 7: Requirements for payer recognition of “disease-modifying” effect in new drug launches

Poster 8: Has The IRA Impacted International Price Differentials? Comparing US And German Drug Prices In The Era Of MFP

Poster 9: Innovation in off-patent competitive environment-: Key learnings from successes and failures

Poster 10*: The 'Soft' Science in 'Hard' Decisions: Utility of qualitative evidence in HTA decisions

*Top 5% Finalists for the ISPOR Europe 2025 Research Presentation Awards

Posters presented at ISPOR Europe, 9–12 November | © ISPOR 2025. All rights reserved.

Our team behind the posters